Back to funds

RA CAPITAL MANAGEMENT, L.P.

Updated 6 days ago

Managed by Ra Capital Management, L.P. • Latest filing Q3 2026

Portfolio value
$10B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$9.8B
Q1 2026$9.4B
Q2 2026$11.5B
Q3 2026$10B

Top holdings

92 positions as of Q3 2026

View filing
A

ASCENDIS PHARMA A/S

Value
$2.3B
Shares
10.28M
% Port
23.50%
P

PARABILIS MEDICINES INC

Value
$942.2M
Shares
29.18M
% Port
9.45%
P

VAXCYTE INC

Value
$652.9M
Shares
11.47M
% Port
6.55%
R

RHYTHM PHARMACEUTICALS INC

Value
$634.8M
Shares
6.67M
% Port
6.37%
E

EDGEWISE THERAPEUTICS INC

Value
$340.7M
Shares
8.39M
% Port
3.42%
T

TYRA BIOSCIENCES INC

Value
$266.8M
Shares
12.20M
% Port
2.68%
F

FREENOME INC

Value
$242M
Shares
15.37M
% Port
2.43%
C

HEMAB THERAPEUTICS HOLDINGS

Value
$240.8M
Shares
7.81M
% Port
2.42%
N

NEWAMSTERDAM PHARMA CO NV

Value
$232.3M
Shares
9.55M
% Port
2.33%
S

SEPTERNA INC

Value
$215.3M
Shares
5.50M
% Port
2.16%
S

SPYGLASS PHARMA INC

Value
$208.5M
Shares
8.02M
% Port
2.09%
J

JANUX THERAPEUTICS INC

Value
$193.4M
Shares
11.19M
% Port
1.94%
M

MINERALYS THERAPEUTICS INC

Value
$193.3M
Shares
7.69M
% Port
1.94%
I

DISC MEDICINE INC

Value
$160.4M
Shares
2.45M
% Port
1.61%
T

TAYSHA GENE THERAPIES INC

Value
$148.2M
Shares
30.44M
% Port
1.49%
B

BICARA THERAPEUTICS INC

Value
$135M
Shares
7.26M
% Port
1.35%
A

ARTIVA BIOTHERAPEUTICS INC

Value
$131.6M
Shares
18.49M
% Port
1.32%
X

XENCOR INC

Value
$131.6M
Shares
5.27M
% Port
1.32%
O

ORUKA THERAPEUTICS INC

Value
$129.5M
Shares
1.55M
% Port
1.30%
A

AMYLYX PHARMACEUTICALS INC

Value
$124.5M
Shares
4.28M
% Port
1.25%

Explore